Analyst consensus rating
Omega Healthcare Investors Analyst Rating: Buy
Direct answer
Omega Healthcare Investors's consensus rating is Buy.
19 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $52.11.
Forecast evidence checked November 21, 2026.
Get free Omega Healthcare Investors email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $45.53
- Average price target
- $52.11
- High price target
- $60.00
- Low price target
- $47.00
- Low target gap
- +3.2%
- Target upside
- +14.4%
- High target gap
- +31.8%
- Target range width
- 28.6%
- Consensus rating
- Buy
- Analysts
- 19
- Evidence date
- November 21, 2026
- Valid through
- November 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Omega Healthcare Investors?
Omega Healthcare Investors has a verified Buy consensus. The same dataset has an average price target of $52.11.
How far are Omega Healthcare Investors's low and high targets from the recorded price?
The low target implies +3.2%, while the high target implies +31.8%.
How many analysts are included in Omega Healthcare Investors's consensus?
The verified consensus includes 19 analysts.
How is Omega Healthcare Investors's target upside or downside calculated?
The average target of $52.11 is divided by the recorded price of $45.53, then one is subtracted to produce +14.4%. This does not guarantee a future return.
When was Omega Healthcare Investors's analyst forecast verified?
The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.